胎儿心肌病的临床表现、遗传病因与结局:两个时期的比较
回顾加拿大阿尔伯塔省2003–2019年38例胎儿心肌病病例,比较2003–2012年与2013–2019年两个时期。后期确诊或高度怀疑遗传病因的比例显著高于早期(76% vs 38%,P=0.04);排除终止妊娠及计划姑息治疗病例后,后期新生儿存活率69%(11/16)vs 早期45%(5/11),差异无统计学意义(P=0.26)。
要点
- 胎儿心肌病常伴结构心脏异常(39%)或心律失常(24%),初诊时29%已出现水肿。
- 后期确诊或高度怀疑遗传病因的比例显著高于早期(76% vs 38%,P=0.04)。
- 排除终止妊娠及计划姑息治疗后,后期新生儿存活率69% vs 早期45%,差异无统计学意义(P=0.26)。
核心结论
- 近期胎儿心肌病病例中确诊或高度怀疑遗传病因的比例较以往报道更高;与较早系列比较,现代围产期管理策略可能对胎儿心肌病新生儿存活率无显著影响,但需要更大样本研究以检测更细微的差异。
研究设计与样本
- 回顾性研究,纳入加拿大阿尔伯塔省2003–2019年诊断的38例胎儿心肌病病例,排除继发于心脏外病理及母体状况的病例,比较2003–2012年与2013–2019年两个时期。
关键影像表现/征象
- 诊断时中位孕周22.8周(范围13.4–37.4周)。
- 39%(15/38)合并结构心脏异常,24%(9/38)合并心律失常。
- 29%(11/38)初诊时存在水肿,另有18%(7/38)在孕期后期出现水肿。
诊断标准与关键数值
- 遗传病因确诊39%(15/38),高度怀疑24%(9/38)。
- 后期确诊或高度怀疑遗传病因76%(19/25)vs 早期38%(5/13),P=0.04。
- 排除终止妊娠及计划姑息治疗病例后,后期新生儿存活率69%(11/16)vs 早期45%(5/11),P=0.26。
临床应用与阅片要点
- 胎儿心肌病评估应关注结构心脏异常、心律失常及水肿的出现与进展。
- 遗传病因检测在近期时期提高了确诊或高度怀疑遗传病因的比例。
- 现代围产期管理策略对新生儿存活率的影响可能不显著。
局限性
- 原文指出需要更大样本研究才能更好地检测更细微的差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To assess the rate and type of genetic diagnosis and clinical outcome of cases of fetal cardiomyopathy (CM) during two eras, in order to examine the impact of advanced genetic testing and improved perinatal management strategies.
METHODS: All diagnoses of fetal CM in Alberta, Canada, encountered between 2003 and 2019, were reviewed retrospectively. Genetic, cardiac and non-cardiac diagnoses and clinical outcome were documented. Cases with CM secondary to extracardiac pathology and maternal conditions were excluded. Cases diagnosed in the earlier era of the study period (2003-2012) were compared with those diagnosed in the later era (2013-2019).
RESULTS: Thirty-eight cases of fetal CM met the inclusion criteria. Median gestational age (GA) at diagnosis was 22.8 (range, 13.4-37.4) weeks. Associated structural heart disease was present in 39% (15/38) of cases and 24% (9/38) had arrhythmia. Hydrops was identified in 29% (11/38) of cases at presentation, and a further 18% (7/38) developed hydrops later in gestation. Twenty-six percent (10/38) of cases underwent termination of pregnancy and 24% (9/38) had intrauterine death. Of liveborn cases, neonatal death occurred in 16% (3/19), late death occurred in 21% (4/19) and 63% (12/19) were alive at the last follow-up. Excluding cases that had termination of pregnancy and those with a liveborn infant who received planned palliative care, the rate of neonatal survival was higher in the later compared with the earlier era (69% (11/16) vs 45% (5/11)), although the difference was not statistically significant (P = 0.26). A genetic etiology was confirmed in 39% (15/38) of cases and strongly suspected in 24% (9/38). A significantly higher proportion of cases had a confirmed or strongly suspected genetic etiology in the later era compared with in the earlier era (76% (19/25) vs 38% (5/13); P = 0.04).
CONCLUSIONS: In the recent era, a higher proportion of fetal CM cases had a confirmed or strongly suspected genetic etiology than reported previously. Based on comparison with older series, modern perinatal management strategies may not have a significant impact on neonatal survival in cases of fetal CM; however, a larger study would be better powered to detect more subtle differences. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Trakmulkichkarn T, Ghadiry-Tavi R, Fruitman D, et al. Clinical presentation, genetic etiology and outcome associated with fetal cardiomyopathy: comparison of two eras. Ultrasound Obstet Gynecol. 2022. PMID: 34159662. doi:10.1002/uog.23713
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。